49.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$54.64
Offen:
$53.16
24-Stunden-Volumen:
6.76M
Relative Volume:
2.81
Marktkapitalisierung:
$7.82B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
53.05
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-13.59%
1M Leistung:
-6.15%
6M Leistung:
-33.52%
1J Leistung:
-36.41%
Bio Techne Corp Stock (TECH) Company Profile
Firmenname
Bio Techne Corp
Sektor
Branche
Telefon
(612) 379-8854
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Vergleichen Sie TECH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TECH
Bio Techne Corp
|
49.87 | 8.57B | 1.17B | 150.71M | 245.03M | 0.94 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-22 | Fortgesetzt | Stephens | Overweight |
2025-07-09 | Eingeleitet | TD Cowen | Buy |
2025-05-30 | Eingeleitet | Wells Fargo | Overweight |
2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
2024-02-08 | Eingeleitet | Scotiabank | Sector Outperform |
2024-02-02 | Herabstufung | Stifel | Buy → Hold |
2023-12-07 | Eingeleitet | UBS | Buy |
2023-08-28 | Eingeleitet | William Blair | Outperform |
2023-01-10 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
2021-09-15 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-08 | Hochstufung | Stephens | Equal-Weight → Overweight |
2021-02-23 | Hochstufung | Stifel | Hold → Buy |
2021-01-25 | Bestätigt | The Benchmark Company | Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
2020-07-15 | Herabstufung | Stephens | Overweight → Equal-Weight |
2020-05-27 | Herabstufung | Stifel | Buy → Hold |
2020-05-14 | Eingeleitet | The Benchmark Company | Buy |
2020-01-08 | Fortgesetzt | Stephens | Overweight |
2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
2020-01-07 | Eingeleitet | Citigroup | Neutral |
2019-11-15 | Eingeleitet | Stifel | Buy |
2019-07-02 | Hochstufung | Janney | Neutral → Buy |
2019-01-14 | Hochstufung | Stephens | Equal-Weight → Overweight |
2018-10-31 | Herabstufung | Craig Hallum | Buy → Hold |
2018-10-17 | Eingeleitet | Goldman | Neutral |
2018-06-15 | Eingeleitet | Argus | Buy |
2017-07-13 | Eingeleitet | Wells Fargo | Market Perform |
2017-02-09 | Eingeleitet | Citigroup | Buy |
2017-01-18 | Eingeleitet | Deutsche Bank | Buy |
2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
2015-01-21 | Bestätigt | Robert W. Baird | Outperform |
2013-09-20 | Hochstufung | Robert W. Baird | Neutral → Outperform |
Alle ansehen
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne (TECH) Q4 EPS Rises 8.2% - The Motley Fool
Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Bio-Techne's Q4 Fiscal 2025 Results Trigger 6.5% Share DeclineNews and Statistics - IndexBox
Why Bio-Techne (TECH) Shares Are Plunging Today - Yahoo Finance
Earnings call transcript: Bio-Techne Q4 2025 beats EPS forecasts - Investing.com
Bio-Techne Q2 2025 Financial Results: Revenue and EPS Surpass ExpectationsNews and Statistics - IndexBox
Bio-Techne Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations - Yahoo Finance
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls - Nasdaq
Bio-Techne Exceeds Forecasts And Refines Its Focus On Growth - Finimize
Bio-Techne Q4 25 Earnings Conference Call At 9:00 AM ET - Nasdaq
Techne (TECH) Beats Q4 Earnings and Revenue Estimates - Nasdaq
Bio-Techne Corp (TECH) Q4 Earnings: Revenue Surpasses Estimates - GuruFocus
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Bio-techne declares quarterly dividend of $0.08 per share - Investing.com
Bio-Techne Earnings Beat Estimates as Cell Therapy Division Drives Growth, Strategic Divestiture Announced - Stock Titan
Dividend Alert: Bio-Techne Sets $0.08 Per Share Payout, Reveals August Payment Timeline - Stock Titan
Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com South Africa
Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com
Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? - MSN
Stock Analysis | Bio-Techne OutlookWeak Technicals but Strong Fundamentals - AInvest
Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow - Yahoo Finance
Why is Bio Techne Corporation stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News
What drives Bio Techne Corporation stock priceExponential wealth increase - Jammu Links News
When is Bio Techne Corporation stock expected to show significant growthGain insights from top financial experts - Jammu Links News
Is Bio Techne Corporation stock overvalued or undervaluedMassive profits - Jammu Links News
How strong is Bio Techne Corporation company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News
Bio Techne Corporation Shows Risk Reward Favoring UpsideAccurate Buy Point for Momentum Stocks Detected - beatles.ru
Is it the right time to buy Bio Techne Corporation stockAI Powered Growth Plan For 2025 - Jammu Links News
Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending - Yahoo Finance
Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns - Yahoo Finance
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering - Yahoo Finance
Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher - TipRanks
Will Bio Techne Corporation stock benefit from interest rate changesLow Risk High Return Opportunities Identified - beatles.ru
Momentum Screeners Rank Bio Techne Corporation in Top 5 TodayReal-Time Trade Insights Spark Market Reactions - metal.it
Why Bio Techne Corporation is moving today Weekly Setup Summary for Risk Controlled Trades - metal.it
How many analysts rate Bio Techne Corporation as a “Buy”Discover the fastest growing stocks today - Jammu Links News
Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen - Insider Monkey
What makes Bio Techne Corporation stock price move sharplyAchieve rapid capital gains with smart investing - Jammu Links News
Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH) - Yahoo Finance
Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - MSN
10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey
Bio-Techne Corporation (TECH): A Bull Case Theory - Yahoo Finance
What analysts say about Bio Techne Corporation stockTriple returns potential - jammulinksnews.com
Bio-Techne (TECH) Stock Is Up, What You Need To Know - Yahoo Finance
Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional
Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest
Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch
Finanzdaten der Bio Techne Corp-Aktie (TECH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):